Literature DB >> 25536945

Patient Management and Psychopharmacological Treatment Associated to Smoking Ban in an Acute Psychiatric Unit.

Daniel Bergé1, Anna Mané, Francina Fonseca, Alba Toll, Ana Merino, Victor Pérez, Antoni Bulbena.   

Abstract

This study investigates differences in terms of clinical and treatment management in psychiatric hospitalization associated to smoking ban. We collected data regarding medication, socio-demographic and admission characteristics from all patients admitted to an acute psychiatric hospital before and after a smoking ban was in force. We also assessed a limited sample of patients before and after the ban regarding nicotine dependence, motivation to quit smoking and attitudes towards the ban. More number of leaves of absence and movement restrictions during the ban period occurred in comparison to the pre-ban period. On the contrary a lack of significant differences in terms of hospital stay (duration, rate of voluntary admissions and voluntary discharges), use of sedatives and doses of antipsychotics was found. A period of adjustment regarding the deal with leave of access and facilitate nicotine replacement treatment may help future psychiatric facilities planning smoking free policies.

Entities:  

Mesh:

Year:  2014        PMID: 25536945     DOI: 10.1007/s10597-014-9823-7

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  29 in total

1.  Smoking and mental health nurses: a survey of clinical staff in a psychiatric hospital.

Authors:  G L Dickens; J H Stubbs; C M Haw
Journal:  J Psychiatr Ment Health Nurs       Date:  2004-08       Impact factor: 2.952

2.  A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine.

Authors:  I Cormac; A Brown; S Creasey; M Ferriter; B Huckstep
Journal:  Acta Psychiatr Scand       Date:  2009-10-13       Impact factor: 6.392

3.  Multivariate models for predicting abstention following intervention to stop smoking by general practitioners.

Authors:  R L Richmond; L A Kehoe; I W Webster
Journal:  Addiction       Date:  1993-08       Impact factor: 6.526

Review 4.  Impact of tobacco smoking cessation on stable clozapine or olanzapine treatment.

Authors:  Erin J Lowe; Margaret L Ackman
Journal:  Ann Pharmacother       Date:  2010-03-16       Impact factor: 3.154

5.  Nicotine replacement prescribing trends in a large psychiatric hospital, before and after implementation of a hospital-wide smoking ban.

Authors:  Deborah Scharf; Tanya Fabian; Cecilia Fichter-DeSando; Antoine Douaihy
Journal:  Nicotine Tob Res       Date:  2011-04-04       Impact factor: 4.244

Review 6.  Drug interactions with smoking.

Authors:  Lisa A Kroon
Journal:  Am J Health Syst Pharm       Date:  2007-09-15       Impact factor: 2.637

Review 7.  Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.

Authors:  Guy Chouinard
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

Review 8.  Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis.

Authors:  Alex J Mitchell; Oliver Lord
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

9.  Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.

Authors:  Nancy C Andreasen; Marcus Pressler; Peg Nopoulos; Del Miller; Beng-Choon Ho
Journal:  Biol Psychiatry       Date:  2009-11-07       Impact factor: 13.382

10.  Environmental tobacco smoke. Health effects and prevention policies. Council on Scientific Affairs, American Medical Association.

Authors: 
Journal:  Arch Fam Med       Date:  1994-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.